ReviewClinical and translational allergy2018
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence.
Erratum issued Registry-linked trialOpen access · goldAbstract readReview
In one paragraph
Review in Clinical and translational allergy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05047419 (Using Mobile Health Approaches to Improve Asthma Treatment), which is not on this map. Cited by 53 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
13.2field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Using Mobile Health Approaches to Improve Asthma Treatment
Who cites it
53 citing papers in PubMed, 1 synthesis or guideline pooled it, 137 citations in OpenAlex.
- Antihistamines in the Management of Pediatric Allergic Rhinitis: A Systematic Review.Paediatric drugs · 2020Pooled it
- eHealth Approaches to Multimorbidity Management: Scoping Review of Interventions and Multidisease Strategies.Online journal of public health informatics · 2026Review
- ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases: An OECD Best Practice for Integrated Care for Chronic Diseases.Clinical and translational allergy · 2026Article
- Moving Towards an Integrated Approach to Allergic Rhinitis Management: ARIA and EUFOREA Guidelines Similarities and Differences.Current allergy and asthma reports · 2025Review
- Nasal eosinophil count and visual analog scale in patients with allergic rhinitis.Allergologie select · 2025Article
- Concurrent validity, cut-offs and ability to change of patient-reported outcome measures for rhinitis and asthma in MASK-airClinical and translational allergy · 2024Article
- Embedding patients' values and preferences in guideline development for allergic diseases: The case study of Allergic Rhinitis and its Impact on Asthma 2024.Clinical and translational allergy · 2024Review
- Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air study.Clinical and translational allergy · 2024Article
- Tele-Monitoring Applications in Respiratory Allergy.Journal of clinical medicine · 2024Review
- Exploring the role of information and communication technologies in allergic rhinitis in specialist centers: Patient perspectives on usefulness, value, and impact on healthcare.Clinical and translational allergy · 2024Article
- Global Asthma Network Phase I Syria asthma surveillance and the impact of the war.Journal of thoracic disease · 2023Article
- ARIA Care Pathways 2019: Next-Generation Allergic Rhinitis Care and Allergen Immunotherapy in Malaysia.Journal of personalized medicine · 2023Review
- Daily allergy burden and heart rate characteristics in adults with allergic rhinitis based on a wearable telemonitoring system.Clinical and translational allergy · 2023Article
- Self-Management in Allergic Rhinitis: Strategies, Outcomes and Integration into Clinical Care.Journal of asthma and allergy · 2023Review
- Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps.Allergologie select · 2023Review
- Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-airClinical and translational allergy · 2023Article
- MASK-airClinical and translational allergy · 2023Article
- Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities.Clinical and translational allergy · 2022Article
- Applicability of the MASK-AirInternational journal of molecular sciences · 2022Article
- Mobile health app for monitoring allergic rhinitis and asthma in real life in Lithuanian MASK-air users.Clinical and translational allergy · 2022Article
Corrections and comments
- Erratum issued
Authors and funding
92 authors at 20 institutions in 27 countries.
J BousquetMACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, Montpellier, France.
S ArnavielheKYomed-INNOV, Montpellier, France.
A BedbrookMACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, Montpellier, France.
M BewickiQ4U Consultants Ltd, London, UK.
D LauneKYomed-INNOV, Montpellier, France.
E Mathieu-DupasKYomed-INNOV, Montpellier, France.
R MurrayMedScript Ltd, Dundalk, Co Louth Ireland.
G L OnoratoMACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, Montpellier, France.
J L Pépin7Laboratoire HP2, Grenoble, INSERM, U1042, Université Grenoble Alpes, Grenoble, France.
R PicardConseil Général de l'Economie Ministère de l'Economie, de l'Industrie et du Numérique, Paris, France.
F PortejoieMACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, Montpellier, France.
E Costa10UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing, University of Porto (Porto4Ageing), Porto, Portugal.
J Fonseca11Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
O Lourenço13Faculty of Health Sciences and CICS - UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
M Morais-AlmeidaAllergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
A Todo-Bom15Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
A A Cruz16ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Vitória da Conquista, Brazil.
J da Silva18Allergy Service, University Hospital of Federal University of Santa Catarina (HU-UFSC), Florianópolis, Brazil.
F S Serpa19Asthma Reference Center, Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria, Vitória, Esperito Santo Brazil.
M IllarioDivision for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
E Menditto21CIRFF, Federico II University, Naples, Italy.
L CecchiSOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.
R Monti23Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino & Mauriziano Hospital, Torino, Italy.
L NapoliConsortium of Pharmacies and Services COSAFER, Salerno, Italy.
M T Ventura25Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
G De Feo26Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
D Larenas-Linnemann27Center of Excellence in Asthma and Allergy, Hospital Médica Sur, México City, Mexico.
M Fuentes PerezMexico City, Mexico.
Y R Huerta VillabolosMexico City, Mexico.
D Rivero-YeverinoPuebla, Puebla Mexico.
E Rodriguez-ZagalCiutad Mexico, Mexico.
F Amat31Allergology Department, Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand-Trousseau (APHP), Paris, France.
I Annesi-Maesano33Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM, UPMC Sorbonne Université, Medical School Saint Antoine, Paris, France.
I BosseLa Rochelle, France.
P Demoly35Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
P Devillier36UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
J F FontaineReims, France.
J Just31Allergology Department, Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand-Trousseau (APHP), Paris, France.
T P Kuna38Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
B Samolinski39Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
A Valiulis40Clinic of Children's Diseases, and Institute of Health Sciences Department of Public Health, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania.
R Emuzyte42Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
V Kvedariene43Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
D RyanWoodbrook Medical Centre, Loughborough, UK.
A Sheikh46Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
P Schmidt-Grendelmeier47Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zürich, Switzerland.
L KlimekCenter for Rhinology and Allergology, Wiesbaden, Germany.
O PfaarCenter for Rhinology and Allergology, Wiesbaden, Germany.
K C Bergmann50Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
R Mösges52Institute of Medical Statistics, and Computational Biology, Medical Faculty, University of Cologne, Cologne, Germany.
T Zuberbier50Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
R E Roller-Wirnsberger54Department of Internal Medicine, Medical University of Graz, Graz, Austria.
P Tomazic55Department of ENT, Medical University of Graz, Graz, Austria.
W J Fokkens56Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
N H Chavannes57Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
S Reitsma56Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
J M AntoISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
V Cardona62Allergy Section, Department of Internal Medicine, Hospital Vall 'dHebron & ARADyAL Research Network, Barcelona, Spain.
T Dedeu63AQuAS, Barcelona, Spain.
J Mullol65Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, University of Barcelona, Barcelona, Spain.
T Haahtela67Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
J SalimäkiAssociation of Finnish Pharmacists, Helsinki, Finland.
S Toppila-Salmi67Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
E Valovirta69Department of Lung Diseases and Clinical Immunology, University of Turku, Turku, Finland.
B Gemicioğlu71Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
A Yorgancioglu72Department of Pulmonary Diseases, Faculty of Medicine, Celal Bayar University, Manisa, Turkey.
N Papadopoulos74Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
E P Prokopakis76Department of Otorhinolaryngology, University of Crete School of Medicine, Heraklion, Greece.
S Bosnic-AnticevichWoolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW Australia.
R O'Hehir78Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC Australia.
J C IvancevichServicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina.
H NeffenDirector of Center of Allergy, Immunology and Respiratory Diseases, Santa Fe, Argentina Center for Allergy and Immunology, Santa Fe, Argentina.
E Zernotti82Universidad Católica de Córdoba, Córdoba, Argentina.
I Kull83Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
E Melen84Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.
M Wickman86Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden.
C Bachert87Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
P HellingsEuforea, Brussels, Belgium.
S Palkonen90EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
C Bindslev-JensenDepartment of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark.
E EllerDepartment of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark.
S Waserman92Department of Medicine, Clinical Immunology and Allergy, McMaster University, Hamilton, ON Canada.
M Sova93University Hospital Olomouc, Olomouc, Czech Republic.
G De VriesPeercode BV, Geldermalsen, The Netherlands.
M van EerdPeercode BV, Geldermalsen, The Netherlands.
I Agache95Faculty of Medicine, Transylvania University, Brasov, Romania.
T Casale96Division of Allergy/Immunology, University of South Florida, Tampa, USA.
M Dykewickz97Section of Allergy and Immunology, Saint Louis University School of Medicine, Saint Louis, MO USA.
R N Naclerio98Johns Hopkins School of Medicine, Baltimore, MD USA.
Y Okamoto99Department of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan.
D V Wallace100Nova Southeastern University, Fort Lauderdale, Florida USA.
MASK study group
Inserm · FRHeidelberg University · DEHelsinki University Hospital · FIMedical University of Graz · ATOdense University Hospital · DKSorbonne Université · FREuropean Regional and Local Health Authorities · BEEuropean Union of Medical Specialists · BEGhent University Hospital · BEJohns Hopkins University · USLeiden University Medical Center · NLManisa Celal Bayar University · TRRegione Campania · ITUniversidad Católica de Córdoba · ARUniversidade do Porto · PTUniversidade Federal da Bahia · BRUniversitat Pompeu Fabra · ESUniversité de Montpellier · FRUniversity Hospital Olomouc · CZUniversity of Beira Interior · PT
Funding
Medical Research Council G1000758
Abstract
mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (
Indexed as
AppARIAAsthmaCare pathwaysMASKmHealthRhinitis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT05047419ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.